Pharmacogenetics in cardiovascular disorders: An update on the principal drugs

Irene M. Predazzi, Ruggiero Mango, Giuseppe D. Norata, Nicola Di Daniele, Domenico Sergi, Francesco Romeo, Giuseppe Novelli

Research output: Contribution to journalArticle

Abstract

In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine.

Original languageEnglish
Pages (from-to)79-85
Number of pages7
JournalAmerican Journal of Cardiovascular Drugs
Volume13
Issue number2
DOIs
Publication statusPublished - Apr 2013

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pharmacogenetics in cardiovascular disorders: An update on the principal drugs'. Together they form a unique fingerprint.

  • Cite this

    Predazzi, I. M., Mango, R., Norata, G. D., Di Daniele, N., Sergi, D., Romeo, F., & Novelli, G. (2013). Pharmacogenetics in cardiovascular disorders: An update on the principal drugs. American Journal of Cardiovascular Drugs, 13(2), 79-85. https://doi.org/10.1007/s40256-013-0020-9